3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Sarcoma
1
NET
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
45
Paclitaxel
45
Carboplatin
39
Magnetic Resonance Spectroscopy
28
olaparib
27
Specimen Handling
26
Cisplatin
24
Bevacizumab
20
Nivolumab
18
Taxes
17
Biopsy
16
Gemcitabine
13
Cyclophosphamide
13
durvalumab
12
Immunoglobulin G
11
Doxorubicin
11
Disulfides
11
Surveys and Questionnaires
10
niraparib
9
liposomal doxorubicin
9
dostarlimab
9
Radiotherapy
8
Brachytherapy
8
lenvatinib
7
fludarabine
7
atezolizumab
7
Letrozole
7
Docetaxel
7
cediranib
6
Platinum
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Radionuclide Imaging
×
Gynecologic
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled